Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Class S T14
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.00
- Day Range
- $1.97–2.01
- 52-Week Range
- $1.66–2.39
- Bid/Ask
- $1.98 / $2.00
- Market Cap
- $1.53 Bil
- Volume/Avg
- 68,700 / 152,466
Key Statistics
- Price/Earnings (Normalized)
- 11.90
- Price/Sales
- 1.60
- Dividend Yield (Trailing)
- 7.91%
- Dividend Yield (Forward)
- 5.86%
- Total Yield
- 7.91%
Company Profile
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 4,619
- Website
- http://www.jydrt.com.cn
Comparables
Valuation
|
Metric
|
T14
|
000908
|
002412
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.90 | — | 13.78 |
Price/Book Value | 1.57 | — | 1.43 |
Price/Sales | 1.60 | 2.58 | 3.03 |
Price/Cash Flow | 31.73 | 49.77 | 26.16 |
Price/Earnings
T14
000908
002412
Financial Strength
|
Metric
|
T14
|
000908
|
002412
|
|---|---|---|---|
Quick Ratio | 1.58 | 0.14 | 1.96 |
Current Ratio | 2.02 | 0.24 | 2.77 |
Interest Coverage | 30.48 | −3.76 | 65.08 |
Quick Ratio
T14
000908
002412
Profitability
|
Metric
|
T14
|
000908
|
002412
|
|---|---|---|---|
Return on Assets (Normalized) | 9.85% | −11.43% | 9.05% |
Return on Equity (Normalized) | 15.62% | −197.44% | 10.91% |
Return on Invested Capital (Normalized) | 13.89% | −18.58% | 10.42% |
Return on Assets
T14
000908
002412
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Zzwrtzmtm | Hpvrn | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Bpflmrvfx | Kmkcfd | $69.1 Bil | |
HLN
| Haleon PLC ADR | Hdbxgszz | Tdj | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Ggptzjxkq | Rcns | $15.7 Bil | |
VTRS
| Viatris Inc | Vlwzzmvrp | Tdb | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Nwlmnyfw | Ctcg | $12.4 Bil | |
CTLT
| Catalent Inc | Dbvpflmsl | Wjrslw | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Wfkqflcv | Pnhm | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Dqgcwkrc | Bxb | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Sjxvfsxt | Fhzkr | $3.5 Bil |